According to Daniel J. Klein, president and CEO of the Patient Access Network Foundation, patients now have an easier time accessing the high-cost treatments they need, thanks to certain policies and programs. Klein also anticipates that a recently-passed law will bring down the prices of some prescription drugs.
According to Daniel J. Klein, president and CEO of the Patient Access Network (PAN) Foundation, patients now have an easier time accessing the high-cost treatments they need, thanks to certain policies and programs. Klein also anticipates that a recently-passed law will bring down the prices of some prescription drugs.
Transcript (slightly modified)
What are the major ways patients can get access to costly medications?
Today, most patients do have some form of health insurance, which is great. Usually, there’s coverage available for even high-cost medications through the various health insurance plans that patient have. Where it becomes challenging is when the health insurance plan may have a high deductible, or co-pay, or co-insurance, and in that case, some patients need additional assistance.
Many patients rely on assistance from the drug manufacturer in the form of a coupon or a co-pay card. Then, patients particularly in Medicare and other federal insurance programs may need to come to a charitable assistance program, like the PAN Foundation. But, by and large, as a result of the Affordable Care Act and the expansion of Medicaid, most people do have access to the treatment that they need.
What impact do you expect the 21st Century Cures Act to have on improving access to medications?
Clearly, the process for approving generic drugs has been slower than most people would like. The high cost of some drugs may be reduced through competition through generics, so I think that there’s every reason to hope that the 21st Century Cures Act will improve the affordability, at least, of some medications, and in that way improve access.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More